Senior insider sale
EVP, GMDA at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$6.44M
13.97K shares
What this filing means
BOZIC CARMEN plans to sell 13.97K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $6.44M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/12/2026ACC: 0001959173-26-003520
Officer· EVP, GMDA
Since Oct 2019
13.97K
Shares to sell
$6.44M
Approx. market value
6.99K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months3
Restricted Stock Vesting
Compensation
2/24/2025
1.85KRestricted Stock Vesting
Compensation
2/17/2025
2.04KRestricted Stock Vesting
Compensation
2/10/2025
3.10KTotal acquired6.99K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/24/2025 | Restricted Stock Vesting Compensation | 1.85K | — |
2/17/2025 | Restricted Stock Vesting Compensation | 2.04K | — |
2/10/2025 | Restricted Stock Vesting Compensation | 3.10K | — |
| Total | 6.99K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
2.33K
Market value
$1.05M
3/27/2026
—Completed
Units to sell
2.33K
Market value
$1.12M
3/13/2026
—Completed
Units to sell
2.33K
Market value
$1.12M
2/27/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
6.99K
Market value
$3.14M
5/12/2026
Total
Units
13.97K
Value
$6.44M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/27/2026 | 2.33K | $1.05M | — | Completed |
3/13/2026 | 2.33K | $1.12M | — | Completed |
2/27/2026 | 2.33K | $1.12M | — | Completed |
| Planned — Approximate Date | ||||
5/12/2026 | 6.99K | $3.14M | NASDAQ | Planned |
| Total | 13.97K | $6.44M | ||